Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
15.81
-0.06 (-0.38%)
Nov 21, 2024, 1:59 PM EST - Market open
Tyra Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 836 | 596 | 318 | 572 | - | - |
| Market Cap Growth | 109.35% | 87.61% | -44.42% | - | - | - |
| Enterprise Value | 485 | 387 | 57 | 260 | - | - |
| Last Close Price | 15.87 | 13.85 | 7.60 | 14.07 | - | - |
| PB Ratio | 2.32 | 2.92 | 1.23 | 1.90 | - | - |
| P/TBV Ratio | 3.42 | 2.92 | 1.23 | 1.90 | - | - |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.01 | 0.00 | 0.01 | -0.05 |
| Quick Ratio | 29.26 | 13.32 | 44.06 | 83.57 | 8.19 | 0.02 |
| Current Ratio | 29.55 | 13.80 | 45.13 | 84.09 | 8.22 | 0.02 |
| Return on Equity (ROE) | -28.66% | -29.92% | -19.77% | -16.65% | -201.38% | - |
| Return on Assets (ROA) | -20.21% | -20.31% | -12.86% | -10.18% | -70.27% | - |
| Return on Capital (ROIC) | -20.96% | -21.21% | -13.07% | -10.36% | -120.22% | - |
| Earnings Yield | -9.89% | -11.59% | -17.41% | -4.60% | - | - |
| FCF Yield | -7.68% | -8.54% | -16.00% | -4.27% | - | - |
| Buyback Yield / Dilution | -25.11% | -1.96% | -203.94% | -793.58% | 41.81% | - |
| Total Shareholder Return | -25.11% | -1.96% | -203.94% | -793.58% | 41.81% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.